Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson’s disease Article First Online: 10 August 2006 Received: 03 December 2005 Accepted: 03 July 2006 DOI:
Cite this article as: Stacy, M. & Hauser, R. J Neural Transm (2007) 114: 211. doi:10.1007/s00702-006-0554-y Summary.
We previously reported that the use of a specifically designed Wearing-Off Questionnaire (WOQ) identified symptoms of wearing-off more frequently than standard assessments conducted by movement disorder specialists during a routine office visit. In the previous study we used a WOQ of 32 symptoms; however this tool was not designed for daily use. In this paper we describe the retrospective development of a simpler, 19-symptom WOQ more suitable for routine clinical use.
Keywords: Parkinson’s disease, wearing-off, non-motor fluctuations References Agid, Y, Olanow, CW, Mizuno, Y 2002 Levodopa: why the controversy Lancet 360 575 PubMed CrossRef Google Scholar Ahlskog, JE, Muenter, MD 2001 Frequency of levodopa-related dyskinesias and motor fluctuations as estimated from the cumulative literature Mov Disord 16 448 458 PubMed CrossRef Google Scholar Chaudhuri, KR, Yates, L, Martinez-Martin, P 2005 The non-motor symptom complex of Parkinson’s disease: a comprehensive assessment is essential Curr Neurol Neurosci Rep 5 275 283 PubMed Google Scholar Dodel, RC, Berger, K, Oertel, WH 2001 Health-related quality of life and healthcare utilisation in patients with Parkinson’s disease: impact of motor fluctuations and dyskinesias Pharmacoeconomics 19 1013 1038 PubMed CrossRef Google Scholar Goetz, CG, Poewe, W, Rascol, O, Sampaio, C 2005 Evidence-based medical review update: pharmacological and surgical treatments of Parkinson’s disease: 2001 to 2004 Mov Disord 20 523 539 PubMed CrossRef Google Scholar Marsden, CD, Parkes, JD 1977 Success and problems of long-term levodopa therapy in Parkinson’s disease Lancet 1 345 349 PubMed CrossRef Google Scholar Olanow, CW, Stocchi, F 2004 COMT inhibitors in Parkinson’s disease: can they prevent and/or reverse levodopa-induced motor complications? Neurology 62 S72 S81 PubMed Google Scholar Parkinson Study Group 1996 Impact of deprenyl and tocopherol treatment on Parkinson’s disease in DATATOP patients not requiring levodopa Ann Neurol 39 29 36 CrossRef Google Scholar Parkinson Study Group 2000 Pramipexole vs. levodopa as initial treatment for Parkinson disease: A randomized controlled trial JAMA 284 1931 1938 CrossRef Google Scholar Stacy, M, Bowron, A, Guttman, M, Hauser, R, Hughes, K, Larsen, JP, et al. 2005 Identification of motor and nonmotor wearing-off in Parkinson’s disease: Comparison of a patient questionnaire versus a clinician assessment Mov Disord 20 726 733 PubMed CrossRef Google Scholar Thomas, K, Samanta, J, Mahant, P, Williamson, K, Stacy, M 2002 The Ali Project: A web-based database for Parkinson’s disease Mov Disord 17 S141 Google Scholar UPDRS Taskforce 2003 The Unified Parkinson’s Disease Rating Scale (UPDRS): status and recommendations Mov Disord 18 738 750 CrossRef Google Scholar Welsh, M, McDermott, MP, Holloway, RG, Plumb, S, Pfeiffer, R, Hubble, J 2003 Development and testing of the Parkinson’s disease quality of life scale Mov Disord 18 637 645 PubMed CrossRef Google Scholar Witjas, T, Kaphan, E, Azulay, JP, Blin, O, Ceccaldi, M, Pouget, J, et al. 2002 Nonmotor fluctuations in Parkinson’s disease: frequent and disabling Neurology 59 408 413 PubMed Google Scholar